Pennsylvania Dutch community launches own drug company to address biopharma access gap

A Pennsylvania Dutch community, frustrated by biopharma's neglect, is building its own drug company to address local healthcare needs. The initiative tests a community-driven model to solve a crisis that larger firms have not addressed. Its viability and impact remain uncertain, but it signals a grassroots response to systemic drug access failures.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works